News Daily News Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment Yael L. Maxwell January 21, 2026
News Daily News JACC Debuts Data Digest on CV Health in the United States Caitlin E. Cox January 12, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Conference News AHA 2025 Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight Caitlin E. Cox November 18, 2025
News Daily News Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis Yael L. Maxwell October 24, 2025
News Daily News High Aerobic Fitness Linked to Less Chronic Disease in Later Life Michael O'Riordan October 10, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Half of Patients Stop Semaglutide for Weight Loss by 1 Year Todd Neale September 18, 2025
News Daily News Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention Todd Neale August 25, 2025
News Daily News AI-Supported Coaching Shows Promise for Improving Glycemic Control L.A. McKeown August 25, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes Todd Neale July 14, 2025